Capital Management Associates Inc Makes New Investment in Tilray Inc (NASDAQ:TLRY)

Capital Management Associates Inc acquired a new stake in shares of Tilray Inc (NASDAQ:TLRY) during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 25,380 shares of the company’s stock, valued at approximately $45,000.

Other hedge funds have also recently made changes to their positions in the company. Tidal Investments LLC increased its holdings in Tilray by 36,687.0% in the 1st quarter. Tidal Investments LLC now owns 10,677,428 shares of the company’s stock worth $26,373,000 after buying an additional 10,648,403 shares during the period. Vanguard Group Inc. increased its stake in shares of Tilray by 3.5% in the first quarter. Vanguard Group Inc. now owns 3,525,160 shares of the company’s stock worth $8,707,000 after acquiring an additional 117,891 shares during the period. Mirae Asset Global Investments Co. Ltd. raised its holdings in shares of Tilray by 8.7% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company’s stock worth $6,699,000 after purchasing an additional 213,834 shares during the last quarter. Bank of Montreal Can lifted its position in Tilray by 19.6% during the second quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock valued at $3,622,000 after purchasing an additional 355,778 shares during the period. Finally, Swiss National Bank boosted its holdings in Tilray by 3.6% in the first quarter. Swiss National Bank now owns 1,490,938 shares of the company’s stock valued at $3,683,000 after purchasing an additional 51,700 shares during the last quarter. 9.35% of the stock is owned by institutional investors and hedge funds.

Tilray Stock Performance

TLRY opened at $1.69 on Friday. The firm has a fifty day moving average price of $1.71 and a 200 day moving average price of $1.80. Tilray Inc has a 1 year low of $1.45 and a 1 year high of $2.97. The stock has a market cap of $1.31 billion, a P/E ratio of -3.84 and a beta of 2.13. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57.

Tilray (NASDAQ:TLRY) last issued its quarterly earnings data on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, hitting analysts’ consensus estimates of ($0.04). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The business had revenue of $200.00 million during the quarter, compared to the consensus estimate of $218.70 million. During the same quarter in the prior year, the firm posted ($0.10) earnings per share. The company’s revenue was up 13.0% compared to the same quarter last year. Equities research analysts anticipate that Tilray Inc will post -0.14 earnings per share for the current year.

Analysts Set New Price Targets

Separately, Roth Mkm reduced their price objective on Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research note on Friday, October 11th.

Tilray Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.